GSK-3β, a pivotal kinase in Alzheimer disease

M Llorens-Marítin, J Jurado, F Hernández… - Frontiers in molecular …, 2014 - frontiersin.org
Alzheimer disease (AD) is the most common form of age-related dementia. The etiology of
AD is considered to be multifactorial as only a negligible percentage of cases have a familial …

Molecular mechanisms of neurodegeneration in Alzheimer's disease

L Crews, E Masliah - Human molecular genetics, 2010 - academic.oup.com
Alzheimer's disease (AD) is characterized by cognitive impairment, progressive
neurodegeneration and formation of amyloid-β (Aβ)-containing plaques and neurofibrillary …

[HTML][HTML] α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice

YH Zhang, DW Wang, SF Xu, S Zhang, YG Fan… - Redox Biology, 2018 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease and is
characterized by neurofibrillary tangles (NFTs) composed of Tau protein. α-Lipoic acid (LA) …

Multifaceted effects of oligodendroglial exosomes on neurons: impact on neuronal firing rate, signal transduction and gene regulation

D Fröhlich, WP Kuo, C Frühbeis… - … of the Royal …, 2014 - royalsocietypublishing.org
Exosomes are small membranous vesicles of endocytic origin that are released by almost
every cell type. They exert versatile functions in intercellular communication important for …

The GSK3 hypothesis of Alzheimer's disease

C Hooper, R Killick, S Lovestone - Journal of neurochemistry, 2008 - Wiley Online Library
J. Neurochem.(2008) 104, 1433–1439. Abstract Glycogen synthase kinase 3 (GSK3) is a
constitutively active, proline‐directed serine/threonine kinase that plays a part in a number of …

Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder

CT Chiu, Z Wang, JG Hunsberger, DM Chuang - Pharmacological reviews, 2013 - ASPET
The mood stabilizers lithium and valproic acid (VPA) are traditionally used to treat bipolar
disorder (BD), a severe mental illness arising from complex interactions between genes and …

Neuroprotective effects of lithium: implications for the treatment of Alzheimer's disease and related neurodegenerative disorders

OV Forlenza, VJR De-Paula… - ACS chemical …, 2014 - ACS Publications
Lithium is a well-established therapeutic option for the acute and long-term management of
bipolar disorder and major depression. More recently, based on findings from translational …

Animal models of Alzheimer's disease and frontotemporal dementia

J Götz, LM Ittner - Nature Reviews Neuroscience, 2008 - nature.com
Insoluble protein aggregates have been linked to Alzheimer's disease (AD) and
frontotemporal dementia (FTD). Recent work in transgenic mice has shed light on the role of …

GSK-3 inhibitors: preclinical and clinical focus on CNS

H Eldar-Finkelman, A Martinez - Frontiers in molecular neuroscience, 2011 - frontiersin.org
Inhibiting glycogen synthase kinase-3 (GSK-3) activity via pharmacological intervention has
become an important strategy for treating neurodegenerative and psychiatric disorders. The …

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

KR Brunden, JQ Trojanowski, VMY Lee - Nature reviews Drug …, 2009 - nature.com
Neuronal inclusions comprised of the microtubule-associated protein tau are found in
numerous neurodegenerative diseases, commonly known as tauopathies. In Alzheimer's …